|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.710 USD | +6.21% |
|
+8.23% | +8.23% |
| Market Cap | 207M 181M 167M 156M 293M 19.5B 299M 2.01B 777M 9.64B 776M 759M 33.41B | P/E 2026 * |
-3.29x | P/E 2027 * | -6.49x |
|---|---|---|---|---|---|
| Enterprise Value | 207M 181M 167M 156M 293M 19.5B 299M 2.01B 777M 9.64B 776M 759M 33.41B | EV / Sales 2026 * |
172x | EV / Sales 2027 * | 4.52x |
| Free-Float |
82.58% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Outlook Therapeutics, Inc.
| 1 day | +6.21% | ||
| 1 week | +8.23% | ||
| Current month | +134.25% | ||
| 1 month | +131.08% | ||
| 3 months | +721.72% | ||
| 6 months | -6.04% | ||
| Current year | +8.23% |
| 1 week | 1.53 | 1.87 | |
| 1 month | 0.68 | 1.88 | |
| Current year | 0.16 | 1.88 | |
| 1 year | 0.16 | 3.39 | |
| 3 years | 0.16 | 37 | |
| 5 years | 0.16 | 65.4 | |
| 10 years | 0.16 | 878.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jahr
CEO | Chief Executive Officer | 54 | 01/07/2025 |
Lawrence Kenyon
CEO | Chief Executive Officer | 60 | 03/12/2024 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Lawrence Kenyon
BRD | Director/Board Member | 60 | 02/08/2018 |
Kurt Hilzinger
BRD | Director/Board Member | 65 | 11/12/2015 |
| Chairman | 41 | 31/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-02 | Buy | Director | 29,000 | 0.0181% | ||
| 05-28 | Gms Ventures & Investments
| Buy | Company | 39,516,849 | 24.6751% | |
| 05-27 | Buy | Chairman | 122,174 | 0.1471% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.21% | +8.23% | +6.88% | -94.86% | 207M | ||
| +0.86% | +7.75% | -4.57% | +3.10% | 46.2B | ||
| +2.19% | +11.71% | +393.31% | +580.42% | 38.71B | ||
| +2.53% | +13.93% | +21.38% | -12.81% | 31.9B | ||
| +1.65% | +3.61% | +16.04% | +55.62% | 31.12B | ||
| -4.16% | -2.58% | +8.94% | +25.31% | 23.77B | ||
| -0.32% | +12.96% | - | - | 16.2B | ||
| +1.37% | +14.53% | +69.64% | +130.07% | 15.05B | ||
| -0.44% | +8.19% | +13.63% | +21.56% | 13.74B | ||
| +3.63% | +9.53% | +103.97% | +98.73% | 13.42B | ||
| Average | +1.35% | +9.05% | +69.91% | +89.68% | 23.03B | |
| Weighted average by Cap. | +0.94% | +8.71% | +88.92% | +131.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.2M 1.05M 970K 908K 1.7M 113M 1.74M 11.66M 4.51M 55.95M 4.51M 4.41M 194M | 45.73M 40.09M 36.96M 34.6M 64.88M 4.31B 66.23M 444M 172M 2.13B 172M 168M 7.39B |
| Net income | -53.44M -46.85M -43.19M -40.43M -75.82M -5.04B -77.39M -519M -201M -2.49B -201M -196M -8.64B | -35.55M -31.17M -28.73M -26.9M -50.44M -3.35B -51.48M -345M -134M -1.66B -133M -131M -5.75B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | $1.710 | +6.21% | 11,491,945 |
| 25/06/26 | $1.610 | -4.17% | 9,147,785 |
| 24/06/26 | $1.680 | -1.18% | 8,676,520 |
| 23/06/26 | $1.700 | -7.10% | 10,792,078 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OTLK Stock
Select your edition
All financial news and data tailored to specific country editions

















